Chan Wung Kim is president and chief executive officer of CKP Therapeutics. Dr. Kim has over 30 years of corporate executive training program experience and has consulted for large companies including Samsung Electronics. His interests include startup funding, venture creation, and IPOs in addition to valuation and risk management. He has succeeded in biotech startup creation and funding. Dr. Kim joined the faculty of the University of Massachusetts Lowell in 2013. Currently, he teaches and is the coordinator of the masters of science in finance program. Dr. Kim obtained a Ph.D. in finance from the University of Iowa.